Resveratrol

A stilbene from grape skin — famous, faddish, and hard for the body to keep

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

Resveratrol is a single plant molecule that grabbed headlines via the ‘French paradox’ and red wine. It’s widely sold in supplements, but the body handles it in a way that makes meaningful dosage a challenge.

This article explains what resveratrol is, where supplements usually source it, why the compound has very low bioavailability in people, and why WellsparQ lists a modest 2.5 mg inclusion as a transparent trace rather than a headline ingredient. It also summarises the regulatory position on health claims for resveratrol.

Ingredient Snapshot

What it is

A plant polyphenol (stilbene) molecule found in grape skins.

Where from

Grape skin (Vitis vinifera) and commercial extracts from Japanese knotweed root.

Known for

Not an essential nutrient; present in small amounts in red wine and has low bioavailability when taken orally.

In WellsparQ

• Acai Moringa Caps2.5 mg

Resveratrol is one of the best-known names in the supplement aisle, and one of the most misunderstood. It rode to fame on the back of a story — the "French paradox," red wine, longevity — and the story has proved far stickier than the science underneath it. WellsparQ includes a small, honest trace of it. This piece explains what resveratrol actually is, where it comes from, why the body struggles to hold on to it, and why 2.5 mg is worth describing as the modest addition it is.

What it is

Resveratrol is a stilbene, a class of plant polyphenol. Plants such as grapevines make it as a defensive compound — a phytoalexin — produced in response to stress, injury or fungal attack, largely in the skin of the grape rather than the flesh. Chemically it exists in two geometric forms, cis and trans; the trans-resveratrol form is the one that predominates in plants and in supplements, and the one nearly all research concerns ^¹.

It is worth being clear from the outset that resveratrol is a single small molecule, not a nutrient. The body has no requirement for it, no deficiency state, and no authorised health claim attaches to it.

Where it comes from

Three sources matter, for three different reasons.

The red-wine connection deserves a plain word. The "French paradox" — an observation from the late twentieth century that some French populations had relatively low rates of heart disease despite a rich diet — was widely attributed in popular media to red wine, and resveratrol became its poster molecule. As cultural history that is genuine and interesting. As nutrition it is a very weak thread: the amounts of resveratrol in wine are small, and any responsible discussion of wine has to weigh the well-established harms of alcohol against a speculative benefit. We mention the paradox as history, not as a reason to drink.

Most resveratrol in capsules today, WellsparQ's included, is derived from Japanese knotweed root, simply because that is where the molecule is most abundant and most economically extracted ^².

The bioavailability problem

This is the single most important, and least advertised, fact about resveratrol: the body absorbs it and then throws most of it straight back out.

The research here is unusually clear and consistent. A frequently-cited human study found that although oral resveratrol is absorbed well from the gut, its bioavailability is very low — because it is metabolised extremely rapidly in the intestinal wall and liver into sulfate and glucuronide conjugates, leaving only trace amounts of the intact molecule circulating in the blood ^³. Laboratory work on human intestinal cells shows the same rapid conjugation ^⁴, and later reviews of resveratrol's pharmacokinetics reach the same conclusion: poor and variable bioavailability is the central obstacle to its use, and the reason so much promising cell-culture data has failed to translate into people ^¹⁵.

In plain terms: what works in a dish, at concentrations a swallowed capsule cannot achieve in the bloodstream, is not a guide to what happens in a person. Much of the research excitement around resveratrol has run aground on exactly this point.

A note on the dose

WellsparQ's declared resveratrol is 2.5 mg, in Acai Moringa Caps. It is honest to describe this as a very modest declared trace — a supporting inclusion, not a headline act. Many resveratrol research studies have used doses in the hundreds of milligrams to a gram or more, and even those ran into the bioavailability wall described above. A 2.5 mg inclusion is a labelled, transparent addition to a botanical blend; it should be presented as exactly that, and nothing more should be read into it.

Source: WellsparQ Supplements Database. The formula is plant-based and suitable for vegetarians and vegans.

Where the evidence stands

Resveratrol has been studied heavily — for cardiovascular, metabolic, ageing and other outcomes — mostly in the laboratory and in animals, with human trials that are smaller, shorter and frequently inconsistent ^¹⁵. Reviews of its clinical use repeatedly return to two themes: mechanistic interest on one hand, and disappointing, hard-to-reproduce human results on the other, with poor bioavailability the recurring culprit ^⁵. That is a fair picture to hold, and a reason for humility rather than enthusiasm.

Regulators have reflected this caution. Under the EU health-claims system, health claims proposed for resveratrol have not been authorised, so no benefit may be stated on-pack or on-page ^⁶.